ACTIVE

M.D.D. PHARMA

Export PDF

Financial year 2026 · Closed on 31/01/2026

Net result370,2 k €-55,1 %over 1 year
Revenue28,6 M €+15,4 %over 1 year
Equity565,9 k €+189,2 %over 1 year
Workforce104,8 ETP-3,2 %over 1 year

Identity

Source · BCE/KBO

M.D.D. PHARMA is a Public limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wavre. It employs on average 104,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0437.759.119
Incorporation
06/07/1989
Legal form
Public limited company
Registered office
Avenue Pasteur 2
1300 Wavre · WallonieSee on map
Contributed capital
122 000,00 €
Latest accounts
31/01/2026
Average workforce
104,8 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 23 filings

Trend over 16 financial years

20262025202420212020
Income statement
Revenue28,6 M €24,8 M €17,8 M €18,4 M €16,1 M €
EBITDA2,2 M €2,3 M €1,9 M €2,4 M €1,8 M €
Operating result863,1 k €1,3 M €1,2 M €2,1 M €1,5 M €
Net result370,2 k €823,9 k €709,3 k €1,5 M €1 M €
Balance sheet
Equity565,9 k €195,7 k €521,8 k €473,1 k €267,2 k €
Total assets12,2 M €11,3 M €9,1 M €6,4 M €5 M €
Cash19,8 k €14,9 k €46,6 k €5,7 k €19 k €
Debts11,3 M €11 M €8,6 M €5,9 M €4,8 M €
Other
Workforce104,8 ETP108,3 ETP99,6 ETP73,3 ETP71,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/01/2026

3 active · 7 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Arnaud Berken
Director02/05/2017 → 17/06/2026Administrator - manager02/05/2017 → 2020 accountsended
Eveline Maryns
Director03/07/2020 → 17/06/2026
Philippe Lacroix
Director01/04/2016 → 17/06/2026Managing director01/04/2016 → 2020 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Gilles Jourquin
Director01/04/2016 → 2020 accounts
Nathalie Loosveldt
Managing director31/03/2009 → 2014 accounts

Other companies at this address

Avenue Pasteur 2 1300 Wavre
CompanyCBE no.
2B CLINIC● Active
0881.533.723
BENU● Active
0436.826.929
BENU Management● Active
0474.171.632
BENU PMCB● Active
0474.171.830
CENTRE RX DE WAVRE● Active
0450.606.867
Créons Ensemble 1● Bankrupt
0731.719.104
Créons Ensemble 2● Bankrupt
0731.719.203
Créons Ensemble 3● Bankrupt
0731.719.302
Dr. Lindita Mustaka, Ophtalmologie● Active
0556.980.037
ESPLANADE DE LA PAIX ONE● Bankrupt
0635.932.691
ESPLANADE DE LA PAIX TWO● Bankrupt
0635.932.889
GREEN CREST CAPITAL INVESTMENT ONE● Bankrupt
0846.594.818
IMMO X● Active
0450.607.065
LLOYDS GROUP● Active
0892.331.902
PAREXEL BELGIUM● Active
0475.837.161
PHOENIX Belgium● Active
0653.962.122
SOFIADIS● Active
0811.294.835
URG ANYTIME● Active
1015.405.601
VAQUAFERRA● Bankrupt
0421.054.432
VAQUALAN Real Estate● Bankrupt
0674.844.539

Full financial information

Source · NBB
202620252024202320222021
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/02/202501/02/202401/04/202301/04/202201/04/202101/04/2020
Closing of the financial year31/01/202631/01/202531/01/202431/03/202331/03/202231/03/2021
Length of the financial year12 months12 months10 months12 months12 months12 months
Filing date25/06/202611/07/202509/07/202403/10/202329/09/202217/09/2021
General meeting17/06/202618/06/202519/06/202411/09/202312/09/202213/09/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 23 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/01/202617/06/202625/06/2026FrenchPDF
Full model31/01/202518/06/202511/07/2025FrenchPDF
Full model31/01/202419/06/202409/07/2024FrenchPDF
Full model31/03/202311/09/202303/10/2023FrenchPDF
Full model31/03/202212/09/202229/09/2022FrenchPDF
Full model31/03/202113/09/202117/09/2021FrenchPDF
Full model31/03/202014/09/202022/10/2020DutchPDF
Full model31/03/202014/09/202022/10/2020FrenchPDF
Full model31/03/201909/09/201912/09/2019DutchPDF
Full model31/03/201909/09/201912/09/2019FrenchPDF
Full model31/03/201810/09/201828/09/2018DutchPDF
Full model31/03/201810/09/201828/09/2018FrenchPDF
Full model31/03/201711/09/201704/10/2017FrenchPDF
Full model31/03/201711/09/201704/10/2017DutchPDF
Abridged model30/06/201518/12/201504/01/2016DutchPDF
Abridged model30/06/201410/12/201423/12/2014DutchPDF
Abridged model30/06/201311/12/201323/12/2013DutchPDF
Abridged model30/06/201212/12/201219/12/2012DutchPDF
Abridged model30/09/201030/03/201127/04/2011DutchPDF
Abridged model30/09/200910/02/201020/05/2010DutchPDF
Abridged model30/09/200831/03/200929/04/2009DutchPDF
Abridged model30/09/200731/03/200824/04/2008DutchPDF
Abridged model30/09/200607/03/200729/03/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/01/2026

3 active · 7 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Arnaud Berken
Director02/05/2017 → 17/06/2026Administrator - manager02/05/2017 → 2020 accountsended
Eveline Maryns
Director03/07/2020 → 17/06/2026
Philippe Lacroix
Director01/04/2016 → 17/06/2026Managing director01/04/2016 → 2020 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Gilles Jourquin
Director01/04/2016 → 2020 accounts
Nathalie Loosveldt
Managing director31/03/2009 → 2014 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates10/07/2026
    Renouvellement du mandat des administrateurs de la Société
    PDF
  • Mandates10/07/2026
    Hernieuwing van de mandaten van de bestuurders van de Vennootschap
    PDF
  • Mandates14/07/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/10/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/10/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other24/07/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Other24/07/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings16 filings
Mandates
Arnaud Berken
Philippe Lacroix
Eveline Maryns
Gilles Jourquin
Simonne Coddens
Wally Loosveldt
Nathalie Loosveldt
Wally De heer Loosveldt
Nathalie Mevrouw Loosveldt
Simonne Mevrouw Coddens
19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
M.D.D. PHARMA
Avenue Pasteur 2, 1300 Wavre
DirectorAdministrator - manager
DirectorManaging director
Director
Director
Director
Director
Managing director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Avenue Pasteur 2, 1300 WavreCurrent
accounts 2024 → 2026
Accounts 2026 · 2026-00229944

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
M.D.D. PHARMACurrent
accounts 2007 → 2026
Accounts 2026 · 2026-00229944

Events

  1. 2026
    Annual accounts 2026370,2 k €↓
  2. 2025
    Annual accounts 2025823,9 k €↑
  3. 2024
    Annual accounts 2024709,3 k €↓
  4. 2021
    Annual accounts 20211,5 M €↑
  5. 2020
    Annual accounts 20201 M €↓
  6. 2019
    Annual accounts 20191,1 M €↓
  7. 2018
    Annual accounts 20181,2 M €↓
  8. 2017
    Annual accounts 20172,5 M €↑
  9. 2015
    Annual accounts 2015521,1 k €↑
  10. 2014
    Annual accounts 2014215,2 k €↑
  11. 2013
    Annual accounts 2013106,8 k €↑
  12. 2012
    Annual accounts 201259,4 k €↑
  13. 2010
    Annual accounts 2010-23,8 k €↓
  14. 2009
    Annual accounts 2009-12,2 k €↓
  15. 2008
    Annual accounts 200836,5 k €↑
  16. 2007
    Annual accounts 200722,1 k €
  17. 06/07/1989
    IncorporationPublic limited company